Scarica l'app Stockscreener
157.76
0.42%
0.66
Pre-mercato:
157.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$157.10
Aprire:
$156.655
Volume 24 ore:
1.04M
Relative Volume:
0.47
Capitalizzazione di mercato:
$37.65B
Reddito:
$222.29B
Utile/perdita netta:
$1.56B
Rapporto P/E:
24.61
EPS:
6.41
Flusso di cassa netto:
$2.44B
1 W Prestazione:
-2.08%
1M Prestazione:
-3.80%
6M Prestazione:
+22.01%
1 anno Prestazione:
+64.61%
Intervallo 1D:
$156.64
$157.79
Intervallo di 1 settimana:
$156.37
$160.97
Portata 52W:
$95.13
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
157.76 | 37.50B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
714.00 | 88.62B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
293.44 | 56.78B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
74.19 | 9.03B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.92 | 793.65M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? - TradingView
What drives Cardinal Health Inc. stock priceBreakthrough profits - Autocar Professional
Are Medical Stocks Lagging Cardinal Health (CAH) This Year? - Yahoo Finance
Cardinal Health Earnings Preview: What to Expect - MSN
Cardinal Health Earnings Preview: What To Expect - Barchart.com
What analysts say about Cardinal Health Inc. stockUnmatched profit potential - jammulinksnews.com
Cardinal Health Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional
Is Cardinal Health Inc. a good long term investmentRapid market gains - jammulinksnews.com
Nitrile Gloves Market Future Business Opportunities 2025-2032 | Cardinal Health, Medline Industries - openPR.com
Cardinal Health Inc. Slips to 489th in Trading Volume Ranking Despite Strategic Investments and Strong Earnings - AInvest
Cardinal Health raises FY25 earnings outlook on investor day - MSN
Cardinal Health Stock (CAH) Opinions on Upcoming Q4 Financial Results - Quiver Quantitative
Cardinal Health's Q3 2025 Success: CEO Jason Hollar's Strategic OverhaulNews and Statistics - IndexBox
Cardinal Health's Earnings Soar 260% After CEO's Turnaround Strategy - AInvest
After earnings fell by $300 million, Cardinal Health’s CEO went ‘ruthless’ to turn it around—and he says workers backed him because ‘people want to win’ - Fortune
Cardinal Health Surges to 347th in Daily Rankings with 3.24 Billion in Trading Volume - AInvest
Investors Appear Satisfied With Cardinal Health, Inc.'s (NYSE:CAH) Prospects - 富途牛牛
Cardinal Health (CAH) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy - ETX View
Radiopharmaceuticals Market Top PlayersGE HealthCare, - openPR.com
Cardinal Health Surges to 331st in Daily Rankings with 3.09 Billion in Trading Volume - AInvest
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2025 on August 12 - The Malaysian Reserve
Cardinal Health: Navigating Growth and Dividends in a Challenging Healthcare Landscape - AInvest
Cardinal Health to Announce Fourth-Quarter and Year-End Results - GuruFocus
Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - MSN
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health's One Voice Initiative: A Strategic Play for Stakeholder Power and Shareholder Returns - AInvest
Cardinal Health (NYSE:CAH) Launches One Voice Initiative Supporting Independent Pharmacy Advocacy - simplywall.st
Cardinal Health Launches One Voice Initiative To Empower Pharmacy Advocacy - Nasdaq
Cardinal Health Launches One Voice Initiative to Bolster Independent Pharmacy Advocacy - AInvest
Cardinal Health announces One Voice Initiative to support indepe - GuruFocus
Cardinal Health Launches One Voice Initiative to Support Independent Pharmacy Advocacy - AInvest
Cardinal Health Launches One Voice Initiative for Pharmacy Advocacy - AInvest
Cardinal Health Unveils Major Financial Initiative to Empower Independent Pharmacy Advocacy Nationwide - Stock Titan
Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries - GlobeNewswire Inc.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - sharewise.com
Cardinal Health (NYSE:CAH) Targets Double-Digit EPS Growth Amid IRA Tailwinds and Healthcare Sector Strength - MSN
Cardinal Health survey reveals 25% of health systems use manual supply tracking; hospitals spent US$147B on medical supplies in 2023, up 4.7% from previous year - Industry Intelligence Inc.
Cardinal Health (CAH) Beat the Market in 2025 with Solid Healthcare Momentum - MSN
Cardinal Health ($CAH) Is Paying a $109M Settlement to Investors — Here’s How to Get Your Share - TradingView
Wound Care Centers Market Report 2025-2030, with Profiles of Smith & Nephew, 3M, Molnlycke Health Care, ConvaTec, Coloplast, Medline, Integra LifeSciences, B. Braun, Cardinal Health, & Derma Sciences - Yahoo Finance
Cardinal Health's (NYSE:CAH) investors will be pleased with their splendid 282% return over the last five years - simplywall.st
Cardinal Health (CAH) Surges Ahead: A Buy for Strong Earnings Momentum and Strategic Value - AInvest
Cardinal Health CEO tops pay rankings, AEP most profitable among Central Ohio public companies - The Business Journals
Cardinal Health Boosts Dividend and Gets Strong Analyst Ratings — What $CAH Investors Should Know - TradingView
Cardinal Health Could Beat Q2 Expectations — And Other News for $CAH Investors - TradingView
Cardinal Health Stock Climbs Ahead of Earnings — And Other News for $CAH Investors - TradingView
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy? - Nasdaq
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.16%
3.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):